Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02752958Completed
Open-label, single-arm trial of stannous fluoride in dentin hypersensitivity (DH), sponsored by GSK. Primary endpoints: Dentine Hypersensitivity Experience Questionnaire Total Score at 24 weeks, Dentine Hypersensitivity Experience Questionnaire Restrictions Domain Score at 24 weeks and 9 more. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02752958.